Dowlati A - Search Results

1

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer.

Pietanza MC, Waqar SN, Krug LM, Dowlati A, Hann CL, Chiappori A, Owonikoko TK, Woo KM, Cardnell RJ, Fujimoto J, Long L, Diao L, Wang J, Bensman Y, Hurtado B, de Groot P, Sulman EP, Wistuba II, Chen A, Fleisher M, Heymach JV, Kris MG, Rudin CM, Byers LA. Pietanza MC, et al. Among authors: dowlati a. J Clin Oncol. 2018 Aug 10;36(23):2386-2394. doi: 10.1200/JCO.2018.77.7672. Epub 2018 Jun 15. J Clin Oncol. 2018. PMID: 29906251 Free PMC article. Clinical Trial.

2

A brief intensive cisplatin-based outpatient chemotherapy regimen with filgrastim and megestrol acetate support for advanced non-small cell lung cancer: results of a phase II trial.

Levitan N, Dowlati A, Craffey M, Tahsildar H, MacKay W, McKenney J, Remick SC. Levitan N, et al. Among authors: dowlati a. Lung Cancer. 1998 Dec;22(3):227-34. doi: 10.1016/s0169-5002(98)00087-7. Lung Cancer. 1998. PMID: 10048475 Clinical Trial.

3

Multi-institutional phase I/II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung carcinoma.

Levitan N, Dowlati A, Shina D, Craffey M, Mackay W, DeVore R, Jett J, Remick SC, Chang A, Johnson D. Levitan N, et al. Among authors: dowlati a. J Clin Oncol. 2000 Mar;18(5):1102-9. doi: 10.1200/JCO.2000.18.5.1102. J Clin Oncol. 2000. PMID: 10694563 Clinical Trial.

4

Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer.

Dowlati A, Levitan N, Gordon NH, Hoppel CL, Gosky DM, Remick SC, Ingalls ST, Berger SJ, Berger NA. Dowlati A, et al. Cancer Chemother Pharmacol. 2001;47(2):141-8. doi: 10.1007/s002800000211. Cancer Chemother Pharmacol. 2001. PMID: 11269740 Clinical Trial.

5

Combination chemotherapy with topotecan for non-small cell lung cancer.

Dowlati A, Levitan N. Dowlati A, et al. Lung Cancer. 2003 Aug;41 Suppl 4:S23-6. doi: 10.1016/s0169-5002(03)90522-8. Lung Cancer. 2003. PMID: 14565511

6

Phase I and correlative study of combination bryostatin 1 and vincristine in relapsed B-cell malignancies.

Dowlati A, Lazarus HM, Hartman P, Jacobberger JW, Whitacre C, Gerson SL, Ksenich P, Cooper BW, Frisa PS, Gottlieb M, Murgo AJ, Remick SC. Dowlati A, et al. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5929-35. Clin Cancer Res. 2003. PMID: 14676117 Clinical Trial.

7

Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer.

Dowlati A, Chapman R, Subbiah S, Fu P, Ness A, Cortas T, Patrick L, Reynolds S, Xu N, Levitan N, Ivy P, Remick SC. Dowlati A, et al. Invest New Drugs. 2005 Dec;23(6):563-7. doi: 10.1007/s10637-005-0754-6. Invest New Drugs. 2005. PMID: 16034518 Clinical Trial.

8

Phase II trial of thalidomide as maintenance therapy for extensive stage small cell lung cancer after response to chemotherapy.

Dowlati A, Subbiah S, Cooney M, Rutherford K, Mekhail T, Fu P, Chapman R, Ness A, Cortas T, Saltzman J, Levitan N, Warren G. Dowlati A, et al. Lung Cancer. 2007 Jun;56(3):377-81. doi: 10.1016/j.lungcan.2007.01.020. Epub 2007 Feb 27. Lung Cancer. 2007. PMID: 17328989 Clinical Trial.

9

Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2.

Lilenbaum R, Axelrod R, Thomas S, Dowlati A, Seigel L, Albert D, Witt K, Botkin D. Lilenbaum R, et al. Among authors: dowlati a. J Clin Oncol. 2008 Feb 20;26(6):863-9. doi: 10.1200/JCO.2007.13.2720. J Clin Oncol. 2008. PMID: 18281658 Clinical Trial.

10

Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab--an Eastern Cooperative Oncology Group Study.

Dowlati A, Gray R, Sandler AB, Schiller JH, Johnson DH. Dowlati A, et al. Clin Cancer Res. 2008 Mar 1;14(5):1407-12. doi: 10.1158/1078-0432.CCR-07-1154. Clin Cancer Res. 2008. PMID: 18316562 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters